Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for EDAP TMS S.A. (EDAP : NSDQ)

• Company Description    EDAP TMS S.A. develops, produces, markets and distributes minimally invasive medical devices, primarily for the treatment of urological diseases. They currently produce and market devices for treatment of benign prostate hyperplasia and urinary tract stones. They are also developing a third range of products for minimally invasive destruction of certain types of tumors. Number of Employees: 310

• Price / Volume Information    Yesterday's Closing Price: $2.17 Daily Weekly Monthly 20 Day Moving Average: 71,861 shares Shares Outstanding: 37.39 (millions) Market Capitalization: $81.14 (millions) Beta: -0.15 52 Week High: $3.05 52 Week Low: $1.21 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -6.87% -8.33% 12 Week 68.22% 56.32% Year To Date -1.81% -15.35%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL Parc d'Activites la Poudrette-Lamartine 4/6 rue du Dauphine - Vaulx-en-Velin,I0 69120 FRA ph: 33-04-72-15-31-50 fax: 33-04-72-15-31-51 jfraunces@lifesciadvisors.com http://www.edap-tms.com

• General Corporate Information    Officers Ryan Rhodes - Chief Executive Officer Marc Oczachowski - Chairman of the Board Ken Mobeck - Chief Financial Officer Marie Meynadier - Independent Director Fran Schulz - Independent Director Peer Information EDAP TMS S.A. (ABMD) EDAP TMS S.A. (DMDS) EDAP TMS S.A. (CPWY.) EDAP TMS S.A. (EQUR) EDAP TMS S.A. (ECIA) EDAP TMS S.A. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 268311107 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/06/25 Share - Related Items Shares Outstanding: 37.39 Most Recent Split Date: (:1) Beta: -0.15 Market Capitalization: $81.14 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.17 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.82 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/06/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.48 Price/Cash Flow: - Price / Sales: 1.18 EPS Growth vs. Year Ago Period: 5.56% vs. Previous Quarter: 15.00% Sales Growth vs. Year Ago Period: 8.61% vs. Previous Quarter: 29.06% ROE 09/30/25 - - 06/30/25 - -56.85 03/31/25 - -51.42 ROA 09/30/25 - - 06/30/25 - -26.83 03/31/25 - -26.43 Current Ratio 09/30/25 - - 06/30/25 - 1.51 03/31/25 - 1.74 Quick Ratio 09/30/25 - - 06/30/25 - 1.05 03/31/25 - 1.21 Operating Margin 09/30/25 - - 06/30/25 - -33.49 03/31/25 - -34.45 Net Margin 09/30/25 - - 06/30/25 - -33.49 03/31/25 - -34.45 Pre-Tax Margin 09/30/25 - - 06/30/25 - -33.00 03/31/25 - -33.90 Book Value 09/30/25 - - 06/30/25 - 0.88 03/31/25 - 0.99 Inventory Turnover 09/30/25 - - 06/30/25 - 1.96 03/31/25 - 1.93 Debt-to-Equity 09/30/25 - - 06/30/25 - 0.04 03/31/25 - 0.10 Debt-to-Capital 09/30/25 - - 06/30/25 - 3.54 03/31/25 - 8.96

Powered by Zacks Investment Research ©